Bondi is developing a novel platform for both the biomanufacture and delivery of biologics.
Our proprietary bioengineered, food-grade cyanobacteria offers a cost-effective, self-formulating, and rapidly-scalable solution for a range of therapeutic modalities.
Our platform has great potential in the manufacture and delivery of VLP-based vaccines, therapeutic proteins & peptides, nucleic-acid-based treatments, and monoclonal antibodies for a wide range of diseases.
Company Details
- Employees
- 6
- Founded
- -
- Address
- Sydney, Australia 2007, Au
- co****@****ndi.bio
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- bondi.bio
- Keywords
- Representative jobs.
- HQ
- Sydney, Australia
Bondi Bio Questions
Bondi Bio's website is bondi.bio
Bondi Bio's LinkedIn profile is https://au.linkedin.com/company/bondibio
Bondi Bio has
6 employees.
View email and phone details for 6
employees at Bondi Bio.
Bondi Bio's industry is
Biotechnology Research
Bondi Bio's top competitors are
Celldzyne Life Sciences Pvt. Ltd.,
Nanomed,
All G,
Glia Diagnostics Pty Ltd,
Synthetic Biology Australasia,
Number 8 Bio,
Levur,
Deep Green Biotech Hub,
Hydgene Renewables,
Entozyme.
Bondi Bio's support email address is contact@bondi.bio
Bondi Bio's categories are Biotechnology Research
Bondi Bio's founding year is 2018
